The Role of LLT1 (CLEC2D, OCIL) in Ewing Sarcoma

Simple item page
dc.contributor.advisorMathew, Stephen O.
dc.contributor.committeeMemberMathew, Porunelloor A.
dc.contributor.committeeMemberJones, Harlan P.
dc.contributor.committeeMemberBasha, Riyaz
dc.contributor.committeeMemberTovar-Vidales, Tara
dc.creatorBuller, Casey W.
dc.date.accessioned2023-04-04T20:32:05Z
dc.date.available2023-04-04T20:32:05Z
dc.date.issued2021-12
dc.description.abstractEwing Sarcoma (EWS) is a pediatric bone cancer that is characterized by a chromosomal translocation giving rise to a neomorphic gene fusion. Although treatment of EWS has a 5-year incident free survival rate of 66%, treatment has plateaued since the 1980's. Natural killer (NK) cells are an important innate immune cell due to their ability to recognize and lyse virally infected and cancerous cells. Unfortunately, cancerous cells often employ strategies such as the downregulation of major histocompatibility complex (MHC) I, or upregulation of inhibitory ligands enabling the escape of T-cells and NK cell mediated killing. LLT1 is an inhibitory ligand our lab had previously shown that it is expressed on TNBC and prostate cancer cell lines. The expression of LLT1 and its function in Ewing Sarcoma (EWS) cell lines has yet to be performed. Our hypothesis is that LLT1 is increased in EWS cell lines TC-32 and CHLA-258 when treated with chemotherapeutic drugs vincristine and etoposide. Our results show that LLT1 is expressed on EWS cell lines and inhibition of LLT1 increases NK cell cytotoxicity. These results indicate that LLT1 is a potential immunotherapy target that needs to be further evaluated in an in vivo model.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12503/32096
dc.language.isoen
dc.subjectEwing sarcoma
dc.subjectimmunotherapy
dc.subjectNK cells
dc.subjectcytotoxicity
dc.subjectLLT1
dc.subjectOCIL
dc.subjectCLEC2D
dc.subject.meshSarcoma, Ewing
dc.subject.meshKiller Cells, Natural
dc.subject.meshCytotoxins
dc.titleThe Role of LLT1 (CLEC2D, OCIL) in Ewing Sarcoma
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentSchool of Biomedical Sciences
thesis.degree.disciplineBiomedical Sciences
thesis.degree.grantorUniversity of North Texas Health Science Center at Fort Worth
thesis.degree.nameMaster of Science

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2021_12_gsbs_Buller_Casey_thesis.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

School of Biomedical Sciences
Theses and Dissertations